Research Report on The Drugs Market of Anti-Senile Dementia
| Publication Date | November 2008 |
|---|---|
| Publisher | Sunfaith China |
| Product Type | Report |
| Pages | 11 |
| ISBN Number | not applicable |
| Product Code | SFC00098 |
Buy this product or for assistance call +44 20 7060 7474
Summary
Since 1999, China has been growing into an aging society. With the increase of aging population, incidents of senile dementia have been on the rise. According to conservative estimates, by the end of 2007, patients of senile dementia in China have amounted to 600 million or so. The search for effective drugs for senile dementia has become one of the major concerns of the worlds medical research.
This report gives a classification of drugs for senile dementia in correspondence with different categories of the disease and makes an analysis of the market situation of a variety of drugs and drug manufacturers.
Content
- 1 Classification of senile dementia
- 1.1 Senile dementia caused by degenarative brain desease
- 1.2 Vascular dementia
- 1.3 Mixed dementia
- 2 Drugs for senile dementia
- 2.1 Drugs for Alzheimer's disease(AD)
- 2.2 Drugs for vascular dementia
- 2.3 The development of drugs for senile dementia
- 3 Chinas Market for drugs for senile dementia
- 3.1 The market demand for drugs for senile dementia
- 3.2 Chinas Market for drugs for senile dementia
- 3.3 Chinas Market for drugs for vascular dementia(VD)
- 3.4 Manufacturers of drugs for senile dementia
Delivery Details
PDF:Delivered by email within 12 to 24 hours of placing the order (Mon-Fri)
Product features / use
| Scope | Concise Overview | ![]() |
| Level | General Industry Strategies | ![]() |
| Data | Detailed Market Forecasts | ![]() |
| Features | Primary Research Data | ![]() |
Related Products
Pharma & Healthcare
- Animal / Veterinary
- Biotechnology
- Cardiovascular
- Company Financials
- Company Reports (Pharmaceutical)
- Country Reports (Pharmaceutical)
- Deals & Alliances
- Dental
- Diagnostics
- Dietary
- Diseases
- Drug Delivery
- Drug Discovery
- Finance / Investment
- General Industry
- Generic Drugs
- Healthcare
- IT & eHealth
- Management / Strategy
- Medical Devices
- Medical Supplies
- OTC drugs
- Pharma Chemicals
- Pharmacy
- Prescription Drugs
- Production / Manufacturing
- Regulation & Policy
- Research (R&D)
- Sales & Marketing
- Technology
- Therapeutic
- Treatments
call +44 (0) 20 7060 7474
or email us
Resources
Why Report Buyer?
Advertising/Affiliates
View Our Publishers
News
About Us
Meet Us
Jobs
Contact Us
Categories and Subcategories












